Correlation Between Nasdaq-100(r) and Biotechnology Ultrasector

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Nasdaq-100(r) and Biotechnology Ultrasector at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nasdaq-100(r) and Biotechnology Ultrasector into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nasdaq 100 2x Strategy and Biotechnology Ultrasector Profund, you can compare the effects of market volatilities on Nasdaq-100(r) and Biotechnology Ultrasector and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nasdaq-100(r) with a short position of Biotechnology Ultrasector. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nasdaq-100(r) and Biotechnology Ultrasector.

Diversification Opportunities for Nasdaq-100(r) and Biotechnology Ultrasector

-0.06
  Correlation Coefficient

Good diversification

The 3 months correlation between Nasdaq-100(r) and Biotechnology is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding Nasdaq 100 2x Strategy and Biotechnology Ultrasector Prof in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biotechnology Ultrasector and Nasdaq-100(r) is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nasdaq 100 2x Strategy are associated (or correlated) with Biotechnology Ultrasector. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biotechnology Ultrasector has no effect on the direction of Nasdaq-100(r) i.e., Nasdaq-100(r) and Biotechnology Ultrasector go up and down completely randomly.

Pair Corralation between Nasdaq-100(r) and Biotechnology Ultrasector

Assuming the 90 days horizon Nasdaq 100 2x Strategy is expected to generate 0.74 times more return on investment than Biotechnology Ultrasector. However, Nasdaq 100 2x Strategy is 1.35 times less risky than Biotechnology Ultrasector. It trades about 0.2 of its potential returns per unit of risk. Biotechnology Ultrasector Profund is currently generating about 0.02 per unit of risk. If you would invest  38,486  in Nasdaq 100 2x Strategy on September 2, 2024 and sell it today you would earn a total of  3,248  from holding Nasdaq 100 2x Strategy or generate 8.44% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Nasdaq 100 2x Strategy  vs.  Biotechnology Ultrasector Prof

 Performance 
       Timeline  
Nasdaq 100 2x 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Nasdaq 100 2x Strategy are ranked lower than 11 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak fundamental indicators, Nasdaq-100(r) showed solid returns over the last few months and may actually be approaching a breakup point.
Biotechnology Ultrasector 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Biotechnology Ultrasector Profund are ranked lower than 1 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong forward indicators, Biotechnology Ultrasector is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Nasdaq-100(r) and Biotechnology Ultrasector Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Nasdaq-100(r) and Biotechnology Ultrasector

The main advantage of trading using opposite Nasdaq-100(r) and Biotechnology Ultrasector positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nasdaq-100(r) position performs unexpectedly, Biotechnology Ultrasector can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotechnology Ultrasector will offset losses from the drop in Biotechnology Ultrasector's long position.
The idea behind Nasdaq 100 2x Strategy and Biotechnology Ultrasector Profund pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Equity Valuation
Check real value of public entities based on technical and fundamental data
Share Portfolio
Track or share privately all of your investments from the convenience of any device